Chronic Kidney Disease. Chronic kidney disease, unspecified
Conditions
Interventions
Intervention 1: The intervention group will receive a daily dose of 100 mg of Coenzyme Q10 tablet (Asia -KarAvaran Manufacturers) for 6 months. Intervention 2: The control group will receive 100 mg of
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of chronic kidney disease Glomerular filtration (GFR) below 60 and above 15 ml / min No history of hospitalization due to kidney disease ovation due to kidney disease over the past three months No increase in creatinine more than 50% over the past three months
Exclusion criteria
Exclusion criteria: Aged less than 18 years old; having allergies Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glomerular filtration rate (GFR). Timepoint: At the beginning of the intervention, 3 months and 6 months after the end of the intervention. Method of measurement: Based on test results.;Uric acid. Timepoint: At the beginning of the intervention, 3 months and 6 months after the end of the intervention. Method of measurement: Based on test results.;Creatinine. Timepoint: At the beginning of the intervention, 3 months and 6 months after the end of the intervention. Method of measurement: Based on test results. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahriar Manoochehri
Kermanshah University of Medical Sciences
Outcome results
None listed